Botfet / Company detail

LGND

rejected

Ligand Pharmaceuticals Incorporated

biotech

Moat scoreNot available: not scored quality failout of 100

Rejectionquality_fail

The numbers

Financial metrics

Quality gate and thesis context

Roic2.4%

Gross Margin97.5%

Revenue Cagr2.6%

Fcf Conversion39.3%

Fcf Yield0.8%

Interest Coverage40.9x

Market Cap B$6.1B

Pe30.3

Quality PassFail

Founder LedNo

Thesis AlignedYes

Moat QuantNot available: not scored quality fail

Why it may endure

Quant: · Curator:

Market Share StabilityNot available: not scored quality fail

Network EffectsNot available: not scored quality fail

Pricing PowerNot available: not scored quality fail

Regulatory MoatNot available: not scored quality fail

Switching CostsNot available: not scored quality fail

ConvictionNot available: not scored quality fail

LeadershipNot available: not scored quality fail

VisionNot available: not scored quality fail